Andrew Ambrosy to Receptors, Vasopressin
This is a "connection" page, showing publications Andrew Ambrosy has written about Receptors, Vasopressin.
Connection Strength
0.134
-
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev. 2012 May; 17(3):485-509.
Score: 0.107
-
Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial. Am Heart J. 2012 Dec; 164(6):884-92.e2.
Score: 0.028